Press Releases May 19, 2026 09:15 AM

Merit Medical Shareholders Elect Scott R. Ward to Board of Directors

Merit Medical Elects Industry Veteran Scott R. Ward to Board of Directors to Bolster Strategic Growth

By Priya Menon MMSI

Merit Medical Systems announced the election of Scott R. Ward to its Board of Directors. Ward brings over 40 years of experience in the medical device industry, including leadership roles at Medtronic and Cardiovascular Systems, Inc., and is expected to contribute significantly to Merit's long-term growth and strategic priorities.

Merit Medical Shareholders Elect Scott R. Ward to Board of Directors
MMSI

Key Points

  • Scott R. Ward was elected to Merit Medical's Board of Directors for a three-year term.
  • Ward's extensive leadership experience in healthcare and medical devices enhances Merit's strategic capabilities.
  • Merit Medical focuses on proprietary medical devices for interventional and diagnostic procedures across multiple healthcare sectors.

SOUTH JORDAN, Utah, May 19, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced that shareholders elected Scott R. Ward to the company’s Board of Directors at Merit’s annual meeting of shareholders.

Mr. Ward was elected to serve a three-year term.

“On behalf of the Board, we are pleased with Scott Ward’s election to Merit’s Board of Directors,” said F. Ann Millner, Merit’s Chair of the Board. “Scott’s extensive industry experience, strategic insight, and commitment to innovation will be tremendous assets as we continue advancing the company’s strategic priorities.”

“We are proud to welcome Scott Ward to Merit’s Board,” said Martha G. Aronson, Merit’s President and Chief Executive Officer. “Scott brings deep medical device experience and a proven leadership track record. As we continue building on our foundation and advancing our strategy, his perspective will be invaluable to our long-term growth.”

“I am honored to join the Merit Board of Directors,” Ward said. “I have great respect for Merit’s commitment to innovation and its focus on serving patients and healthcare providers around the world. I look forward to contributing my experience as the company continues to grow and expand its impact.”

Mr. Ward brings more than 40 years of experience in the healthcare and medical device industry, including nearly three decades at Medtronic, where he held senior leadership roles such as senior vice president and president of the cardiovascular, neurological, and diabetes businesses. He most recently served as CEO, President and Chairman of Cardiovascular Systems, Inc., leading the company through a period of expansion and its acquisition by Abbott.

Mr. Ward is also the founder of Raymond Holdings, a firm focused on venture capital, strategy, and advisory services for medical technology and life sciences companies, and has served on numerous public and private company boards. Merit’s Board of Directors has appointed Mr. Ward to serve on its Governance and Sustainability and Finance and Operating Committees.

ABOUT MERIT MEDICAL

Founded in 1987, Merit is engaged in the development, manufacture, and distribution of proprietary medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves customers worldwide with a domestic and international sales force and clinical support team totaling more than 800 individuals. Merit employs approximately 7,600 people worldwide.

TRADEMARKS

Unless noted otherwise, trademarks and registered trademarks used in this release are the property of Merit Medical Systems, Inc., its subsidiaries, or its licensors.

CONTACTS
Media Inquiries
Sarah Comstock

Merit Medical
+1-801-432-2864 | [email protected]

Investor Inquiries
Mike Piccinino, CFA, IRC

ICR Healthcare
+1-443-213-0509 | [email protected]


Risks

  • Integration risk relating to Ward's influence on company strategy and potential shifts in corporate direction.
  • Market competition in medical devices could impact Merit's ability to capitalize on strategic initiatives supported by Ward's expertise.
  • Healthcare regulatory changes may affect Merit Medical's operations and growth prospects amidst its ongoing strategic development.

More from Press Releases

Verizon declares quarterly dividend on June 4, 2026 Jun 4, 2026 AmperCap Acquisition Company Completes its $125,000,000 Initial Public Offering Jun 4, 2026 Algoma Steel Releases 2025 Sustainability Report Jun 4, 2026 SOLV Energy Announces Full Exercise and Closing of Underwriters’ Option to Purchase Additional Shares of Class A Common Stock Jun 4, 2026 NRx Pharmaceuticals, Inc. Announces Closing of $22.3 Million Public Offering of Common Stock and Including Exercise of the Underwriters’ Option Jun 4, 2026